ILLUMINA INC (ILMN) Fundamental Analysis & Valuation

NASDAQ:ILMN • US4523271090

124.62 USD
-3.62 (-2.82%)
At close: Mar 6, 2026
124.6 USD
-0.02 (-0.02%)
After Hours: 3/6/2026, 8:26:38 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ILMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, ILMN scores 6 out of 10 in our fundamental rating. ILMN was compared to 57 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making ILMN a very profitable company, without any liquidiy or solvency issues. ILMN has a decent growth rate and is not valued too expensively. With these ratings, ILMN could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. ILMN Profitability Analysis

1.1 Basic Checks

  • In the past year ILMN was profitable.
  • In the past year ILMN had a positive cash flow from operations.
  • In multiple years ILMN reported negative net income over the last 5 years.
  • ILMN had a positive operating cash flow in each of the past 5 years.
ILMN Yearly Net Income VS EBIT VS OCF VS FCFILMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • The Return On Assets of ILMN (12.79%) is better than 96.49% of its industry peers.
  • The Return On Equity of ILMN (31.22%) is better than 96.49% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.63%, ILMN belongs to the top of the industry, outperforming 92.98% of the companies in the same industry.
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROIC 13.63%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ILMN Yearly ROA, ROE, ROICILMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • ILMN has a better Profit Margin (19.57%) than 92.98% of its industry peers.
  • In the last couple of years the Profit Margin of ILMN has remained more or less at the same level.
  • ILMN has a better Operating Margin (20.29%) than 87.72% of its industry peers.
  • ILMN's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 66.61%, ILMN belongs to the best of the industry, outperforming 91.23% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ILMN has remained more or less at the same level.
Industry RankSector Rank
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
ILMN Yearly Profit, Operating, Gross MarginsILMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ILMN Health Analysis

2.1 Basic Checks

  • ILMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ILMN has been reduced compared to 1 year ago.
  • The number of shares outstanding for ILMN has been increased compared to 5 years ago.
  • The debt/assets ratio for ILMN has been reduced compared to a year ago.
ILMN Yearly Shares OutstandingILMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ILMN Yearly Total Debt VS Total AssetsILMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 4.31 indicates that ILMN is not in any danger for bankruptcy at the moment.
  • ILMN has a better Altman-Z score (4.31) than 82.46% of its industry peers.
  • The Debt to FCF ratio of ILMN is 2.14, which is a good value as it means it would take ILMN, 2.14 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ILMN (2.14) is better than 89.47% of its industry peers.
  • ILMN has a Debt/Equity ratio of 0.55. This is a neutral value indicating ILMN is somewhat dependend on debt financing.
  • ILMN has a Debt to Equity ratio of 0.55. This is in the lower half of the industry: ILMN underperforms 64.91% of its industry peers.
  • Although ILMN's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Altman-Z 4.31
ROIC/WACC1.27
WACC10.74%
ILMN Yearly LT Debt VS Equity VS FCFILMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • ILMN has a Current Ratio of 2.08. This indicates that ILMN is financially healthy and has no problem in meeting its short term obligations.
  • ILMN has a Current ratio of 2.08. This is comparable to the rest of the industry: ILMN outperforms 42.11% of its industry peers.
  • ILMN has a Quick Ratio of 1.72. This is a normal value and indicates that ILMN is financially healthy and should not expect problems in meeting its short term obligations.
  • ILMN has a Quick ratio (1.72) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.72
ILMN Yearly Current Assets VS Current LiabilitesILMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ILMN Growth Analysis

3.1 Past

  • ILMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.96%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 1.51% on average over the past years.
  • Looking at the last year, ILMN shows a decrease in Revenue. The Revenue has decreased by -0.66% in the last year.
  • Measured over the past years, ILMN shows a small growth in Revenue. The Revenue has been growing by 6.04% on average per year.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.14% on average over the next years. This is quite good.
  • Based on estimates for the next years, ILMN will show a small growth in Revenue. The Revenue will grow by 6.06% on average per year.
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue Next Year5.78%
Revenue Next 2Y5.64%
Revenue Next 3Y5.85%
Revenue Next 5Y6.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ILMN Yearly Revenue VS EstimatesILMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILMN Yearly EPS VS EstimatesILMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. ILMN Valuation Analysis

4.1 Price/Earnings Ratio

  • ILMN is valuated quite expensively with a Price/Earnings ratio of 25.69.
  • Compared to the rest of the industry, the Price/Earnings ratio of ILMN indicates a somewhat cheap valuation: ILMN is cheaper than 70.18% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ILMN to the average of the S&P500 Index (26.29), we can say ILMN is valued inline with the index average.
  • ILMN is valuated rather expensively with a Price/Forward Earnings ratio of 24.07.
  • Based on the Price/Forward Earnings ratio, ILMN is valued a bit cheaper than the industry average as 71.93% of the companies are valued more expensively.
  • ILMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.69
Fwd PE 24.07
ILMN Price Earnings VS Forward Price EarningsILMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ILMN is valued a bit cheaper than the industry average as 77.19% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ILMN indicates a rather cheap valuation: ILMN is cheaper than 82.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.45
EV/EBITDA 17.15
ILMN Per share dataILMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ILMN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.81
PEG (5Y)17.02
EPS Next 2Y10.5%
EPS Next 3Y9.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ILMN Dividend Analysis

5.1 Amount

  • ILMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILMN Fundamentals: All Metrics, Ratios and Statistics

ILLUMINA INC

NASDAQ:ILMN (3/6/2026, 8:26:38 PM)

After market: 124.6 -0.02 (-0.02%)

124.62

-3.62 (-2.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners105.54%
Inst Owner Change-0.86%
Ins Owners0.17%
Ins Owner Change-0.38%
Market Cap19.05B
Revenue(TTM)4.34B
Net Income(TTM)850.00M
Analysts73.57
Price Target138.42 (11.07%)
Short Float %5.2%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.14%
Min EPS beat(2)7.62%
Max EPS beat(2)12.65%
EPS beat(4)4
Avg EPS beat(4)9.22%
Min EPS beat(4)1.33%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)14.29%
EPS beat(12)10
Avg EPS beat(12)229.93%
EPS beat(16)13
Avg EPS beat(16)175.4%
Revenue beat(2)1
Avg Revenue beat(2)1.24%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)2.75%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)2.75%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.88%
PT rev (1m)4.67%
PT rev (3m)14.9%
EPS NQ rev (1m)-6.53%
EPS NQ rev (3m)-4.42%
EPS NY rev (1m)0.04%
EPS NY rev (3m)2.37%
Revenue NQ rev (1m)1.3%
Revenue NQ rev (3m)1.96%
Revenue NY rev (1m)3.03%
Revenue NY rev (3m)3.79%
Valuation
Industry RankSector Rank
PE 25.69
Fwd PE 24.07
P/S 4.38
P/FCF 20.45
P/OCF 17.65
P/B 6.99
P/tB 13.6
EV/EBITDA 17.15
EPS(TTM)4.85
EY3.89%
EPS(NY)5.18
Fwd EY4.15%
FCF(TTM)6.09
FCFY4.89%
OCF(TTM)7.06
OCFY5.67%
SpS28.42
BVpS17.82
TBVpS9.16
PEG (NY)3.81
PEG (5Y)17.02
Graham Number44.1
Profitability
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROCE 17.41%
ROIC 13.63%
ROICexc 20.13%
ROICexgc 32.79%
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
FCFM 21.44%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y1.94%
ROICexgc growth 5Y5.2%
ROICexc growth 3Y74.03%
ROICexc growth 5Y4.4%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Debt/EBITDA 1.29
Cap/Depr 54.81%
Cap/Sales 3.41%
Interest Coverage 9.27
Cash Conversion 93.74%
Profit Quality 109.53%
Current Ratio 2.08
Quick Ratio 1.72
Altman-Z 4.31
F-Score8
WACC10.74%
ROIC/WACC1.27
Cap/Depr(3y)45.45%
Cap/Depr(5y)67.5%
Cap/Sales(3y)3.56%
Cap/Sales(5y)5.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year5.78%
Revenue Next 2Y5.64%
Revenue Next 3Y5.85%
Revenue Next 5Y6.06%
EBIT growth 1Y36.38%
EBIT growth 3Y34.38%
EBIT growth 5Y8.17%
EBIT Next Year32.05%
EBIT Next 3Y17.05%
EBIT Next 5Y16.57%
FCF growth 1Y31.31%
FCF growth 3YN/A
FCF growth 5Y0.88%
OCF growth 1Y28.91%
OCF growth 3Y40.15%
OCF growth 5Y-0.02%

ILLUMINA INC / ILMN FAQ

Can you provide the ChartMill fundamental rating for ILLUMINA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ILMN.


Can you provide the valuation status for ILLUMINA INC?

ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (ILMN). This can be considered as Fairly Valued.


How profitable is ILLUMINA INC (ILMN) stock?

ILLUMINA INC (ILMN) has a profitability rating of 7 / 10.


What is the financial health of ILLUMINA INC (ILMN) stock?

The financial health rating of ILLUMINA INC (ILMN) is 7 / 10.


What is the expected EPS growth for ILLUMINA INC (ILMN) stock?

The Earnings per Share (EPS) of ILLUMINA INC (ILMN) is expected to grow by 6.75% in the next year.